248 related articles for article (PubMed ID: 17164111)
1. Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapy.
Thomas MB
Crit Rev Oncol Hematol; 2007 Jan; 61(1):44-51. PubMed ID: 17164111
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapies for cancer of the gallbladder.
Thomas MB
Curr Opin Gastroenterol; 2008 May; 24(3):372-6. PubMed ID: 18408467
[TBL] [Abstract][Full Text] [Related]
3. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
[TBL] [Abstract][Full Text] [Related]
4. [Survival benefits of chemotherapy for unresectable biliary tract cancer--a multicenter retrospective analysis].
Funakoshi A; Horiuchi H; Sakai T; Miyahara T; Muranaka T; Nakamura M; Mizumoto K; Ueki T; Taketomi A; Yamaguchi H; Sumii T; Ito T
Gan To Kagaku Ryoho; 2010 Dec; 37(13):2875-9. PubMed ID: 21160263
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy in cancers of the gallbladder and bile ducts].
Okada S; Okazaki N
Gan To Kagaku Ryoho; 1991 Jul; 18(8):1269-72. PubMed ID: 2069397
[TBL] [Abstract][Full Text] [Related]
6. Gallbladder and biliary tract carcinoma: A comprehensive update, Part 1.
Rajagopalan V; Daines WP; Grossbard ML; Kozuch P
Oncology (Williston Park); 2004 Jun; 18(7):889-96. PubMed ID: 15255172
[TBL] [Abstract][Full Text] [Related]
7. Gallbladder and biliary tract carcinoma: A comprehensive update, Part 2.
Daines WP; Rajagopalan V; Grossbard ML; Kozuch P
Oncology (Williston Park); 2004 Jul; 18(8):1049-59; discussion 1060, 1065-6, 1068. PubMed ID: 15328897
[TBL] [Abstract][Full Text] [Related]
8. Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002.
Goodman MT; Yamamoto J
Cancer Causes Control; 2007 May; 18(4):415-22. PubMed ID: 17264972
[TBL] [Abstract][Full Text] [Related]
9. Familial Risk of Biliary Tract Cancers: A Population-Based Study in Utah.
Samadder NJ; Smith KR; Wong J; Hanson H; Boucher K; Burt RW; Charlton M; Byrne KR; Gallegos-Orozco JF; Koptiuch C; Curtin K
Dig Dis Sci; 2016 Dec; 61(12):3627-3632. PubMed ID: 27655103
[TBL] [Abstract][Full Text] [Related]
10. Emerging treatment with systemic chemotherapy and targeted agents for biliary cancers.
Boku N
Curr Opin Investig Drugs; 2010 Jun; 11(6):653-60. PubMed ID: 20496260
[TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthase and dihydropyrimidine dehydrogenase are upregulated in pancreatic and biliary tract cancers.
Shimoda M; Sawada T; Kubota K
Pathobiology; 2009; 76(4):193-8. PubMed ID: 19571608
[TBL] [Abstract][Full Text] [Related]
12. [Management of biliary tract carcinomas].
Delbaldo C; Laurent A; Grenier J; Cherqui D; Luciani A; Piedbois P
Rev Prat; 2009 Apr; 59(4):469-73. PubMed ID: 19462864
[TBL] [Abstract][Full Text] [Related]
13. Biliary Tract Cancer: Epidemiology, Radiotherapy, and Molecular Profiling.
Bridgewater JA; Goodman KA; Kalyan A; Mulcahy MF
Am Soc Clin Oncol Educ Book; 2016; 35():e194-203. PubMed ID: 27249723
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy in biliary tract cancer: 2009 update.
Tonini G; Virzì V; Fratto ME; Vincenzi B; Santini D
Future Oncol; 2009 Dec; 5(10):1675-84. PubMed ID: 20001803
[TBL] [Abstract][Full Text] [Related]
15. Systemic and targeted therapy for biliary tract tumors and primary liver tumors.
Thomas MB
Surg Oncol Clin N Am; 2014 Apr; 23(2):369-81. PubMed ID: 24560115
[TBL] [Abstract][Full Text] [Related]
16. Biliary tract cancers: molecular profiling as a tool for treatment decisions. A literature review.
Berardi R; Scartozzi M; Freddari F; Squadroni M; Santinelli A; Bearzi I; Fabris G; Cascinu S
Cancer Treat Rev; 2006 Aug; 32(5):333-47. PubMed ID: 16762510
[TBL] [Abstract][Full Text] [Related]
17. Geographical distribution of biliary tract cancer in Niigata prefecture.
Kato K; Akai S
Jpn J Clin Oncol; 1990 Mar; 20(1):67-71. PubMed ID: 2319700
[TBL] [Abstract][Full Text] [Related]
18. Toward personalized treatment of advanced biliary tract cancers.
Geynisman DM; Catenacci DV
Discov Med; 2012 Jul; 14(74):41-57. PubMed ID: 22846202
[TBL] [Abstract][Full Text] [Related]
19. Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.
Van Dyke AL; Shiels MS; Jones GS; Pfeiffer RM; Petrick JL; Beebe-Dimmer JL; Koshiol J
Cancer; 2019 May; 125(9):1489-1498. PubMed ID: 30645774
[TBL] [Abstract][Full Text] [Related]
20. The epidemiological trends of biliary tract cancers in the United States of America.
Jiang Y; Jiang L; Li F; Li Q; Yuan S; Huang S; Fu Y; Yan X; Chen J; Li H; Li S; Liu J
BMC Gastroenterol; 2022 Dec; 22(1):546. PubMed ID: 36581813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
